Becotatug Vedotin for squamous cell carcinoma of head and neck

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 14 May 2026: Trial registered, NCT07586124
  2. 6 Jul 2026: Trial started, NCT07586124

The trials

NCT07586124: Pucotenlimab Plus Becotatug Vedotin in Perioperative Treatment of Locally Advanced Resectable Head and Neck Squamous Cell Carcinoma

State
Under way
Phase
Phase 2
People
80 planned
Started
6 Jul 2026
Primary completion
Dec 2027
Arms
locally advanced resectable HNSCC Becotatug Vedotin +Pucotenlimab
Results
None posted
  1. 14 May 2026: Trial registered
  2. 6 Jul 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Becotatug Vedotin for Injection, MRG006A.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.